Useful resources |
Beta-lactam versus beta-lactam-aminoglycoside combination therapy in cancer patients with neutropenia (Cochrane Review) ABSTRACT Background: Chemotherapy treated cancer patients are prone to neutropenia and life-threatening infections. Early, empirical antibiotic treatment is therefore administered routinely to febrile neutropaenic patients. Currently, either beta-lactam-aminoglycoside co . . . |
Full article: The full article is available on Wiley InterScience at http://www.thecochranelibrary.com |